← Open Payments lookup

LINDSAY GRAY: Open Payments

NPI 1508407594 · RENO, NV. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$984 in 35 payments from 17 companies in 2025. Trend: 2023 $558 · 2024 $759 · 2025 $984

Food & beverage: $984
CompanyPaymentsAmount
Travere Therapeutics, Inc.5$146
Alexion Pharmaceuticals, Inc.1$135
Apellis Pharmaceuticals, Inc.3$119
Novartis Pharmaceuticals Corporation3$98
Amgen Inc.4$91
Bayer Healthcare Pharmaceuticals Inc.3$56
Calliditas Therapeutics US Inc.3$55
Regeneron Healthcare Solutions, Inc.2$48
Otsuka America Pharmaceutical, Inc.2$45
Outset Medical Inc1$36

Products named: ULTOMIRIS, Filspari, Fabhalta, KRYSTEXXA, DUPIXENT, Kerendia, TARPEYO, JYNARQUE.

Industry payments across NV — which companies pay providers there.